A Study to Evaluate the Effect of Two Fixed-Dose Leucine, Sildenafil and Metformin Combinations on Blood Pressure in Individuals With Hypertension
A phase 2 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 150 participants.
Also called NCT07647003
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 150 participants
- Registry
-
NCT07647003
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07647003. Randomized; quadruple masking; primary purpose treatment. Start 2026-10-15 (anticipated); primary completion 2027-05-02 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study to Evaluate the Effect of Two Fixed-Dose Leucine, Sildenafil and Metformin Combinations on Blood Pressure in Individuals With Hypertension
- Acronym
- NS-HTN-01
- Condition
- Hypertension
- Intervention (Drug)
- NS-0200 (low sildenafil)
- Intervention (Drug)
- NS-0200 (higher sildenafil)
- Intervention (Other)
- Placebo
- Lead sponsor
- NuSirt Biopharma
- Collaborator
- National Heart, Lung, and Blood Institute (NHLBI)
Record details
- Record id
cardio:ct-nct07647003- Content hash
638b08f2c0a4ca54d014a17676b2307564344eb5669a6ae87a624cade247c263